Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.

Eitemau Tebyg

• Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.
  gan: Paleolog, E, et al.
  Cyhoeddwyd: (1996)
• Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
  gan: Feldmann, M, et al.
  Cyhoeddwyd: (1997)
• Similarities in the mechanisms of action of pulse corticosteroids and anti-tumor necrosis factor alpha therapy in rheumatoid arthritis - Reply
  gan: Maini, R, et al.
  Cyhoeddwyd: (1998)
• Use of anti-tumor necrosis factor antibodies in rheumatoid arthritis.
  gan: Feldmann, M, et al.
  Cyhoeddwyd: (1994)
• Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
  gan: Elliott, M, et al.
  Cyhoeddwyd: (1994)